SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001082554-24-000025
Filing Date
2024-05-01
Accepted
2024-05-01 06:32:23
Documents
81
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q uthr-20240331.htm   iXBRL 10-Q 1656626
2 EX-31.1 uthrex31103312024.htm EX-31.1 11938
3 EX-31.2 uthrex31203312024.htm EX-31.2 11944
4 EX-32.1 uthrex32103312024.htm EX-32.1 6644
5 EX-32.2 uthrex32203312024.htm EX-32.2 6771
  Complete submission text file 0001082554-24-000025.txt   8453892

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20240331.xsd EX-101.SCH 53199
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20240331_cal.xml EX-101.CAL 82473
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20240331_def.xml EX-101.DEF 295610
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT uthr-20240331_lab.xml EX-101.LAB 736690
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20240331_pre.xml EX-101.PRE 511105
85 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20240331_htm.xml XML 1272604
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 24899958
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)